WallStSmart
NBTX

Nanobiotix

NASDAQ: NBTX · HEALTHCARE · BIOTECHNOLOGY

$32.99
-0.39% today

Updated 2026-04-29

Market cap
$1.60B
P/E ratio
P/S ratio
49.09x
EPS (TTM)
$-0.59
Dividend yield
52W range
$3 – $42
Volume
0.1M

Nanobiotix (NBTX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-4.87M$-3.76M$-6.83M$-8.56M$-16.82M$-18.28M$-20.95M$-25.98M$-41.17M$-27.54M$-29.87M$-37.10M$-12.48M$-19.55M$-33.42M
Capital expenditures$0.00$45391.00$196322.00$963258.00$1.49M$400101.00$1.34M$416000.00$1.09M$96000.00$228000.00$92000.00$328000.00$846000.00$546000.00
Depreciation$197616.00$146533.00$233929.00$307560.00$456080.00$482794.00$403852.00$619000.00$1.77M$1.75M$1.56M$1.50M$1.51M$1.62M
Stock-based comp$266256.00$451196.00$597958.00$252257.00$1.29M$1.99M$2.60M$1.87M$4.32M$2.92M$3.20M$3.17M$3.30M$4.30M$3.54M
Free cash flow$-4.87M$-3.80M$-7.03M$-9.53M$-18.32M$-18.68M$-22.29M$-26.40M$-42.26M$-27.63M$-30.10M$-37.20M$-12.80M$-20.40M$-33.97M
Investing cash flow$4.95M$-49510.00$-192311.00$-1.14M$-2.21M$-444986.00$-1.46M$71000.00$-1.46M$-112000.00$-242000.00$138000.00$-349000.00$-955000.00
Financing cash flow$177373.00$15.30M$-358129.00$37.71M$3.06M$22.90M$48.53M$14.85M$41.49M$111.77M$-5.18M$-5.65M$46.77M$-5.13M
Dividends paid$1.00M$770645.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash